In basal-like breast cancers, especially in chemotherapy resistant triple negative breast cancer (TNBC), low DUSP4 mRNA is coupled with high RAS-ERK activation, that also relates to shorter recurrence free survival [38]. This evidence concerns the gene DUSP4 and breast carcinoma.